The importance of community development for health and well-being

Public health - Economic aspects

Dmitri Shalin Interview with S. Leonard Syme about Erving Goffman entitled Erving Looked at the Room and Announced, “I See Everyone Is Observing the Rituals of Mourning”

This interview with S. Leonard Syme, Professor Emeritus at the University of California, Berkeley, was recorded in Las Vegas on October 12, 2011. Dmitri Shalin transcribed the interview, after which Dr. Syme edited the transcript and approved posting the present version in the Erving Goffman Archives. Breaks in the conversation flow are indicated by ellipses. Supplementary information and additional materials inserted during the editing process appear in square brackets. Undecipherable words and unclear passages are identified in the text as “[?]”

Historical Perspective: The social determinants of disease – some roots of the movement

This is an account of the early days of research on social determinants as I experienced them. I describe my time as one of four Fellows in a new training program in Medical Sociology at Yale University and how I came to be the first Sociologist employed in the U.S. Public Health Service. I then became the first Executive Secretary of a new Study Section at NIH dealing with a small number of research grant proposals in the field of Epidemiology. My account deals with some of my experiences in this developing field, culminating with my appointment as the first Sociologist to become a Professor of Epidemiology in a School of Public Health

Can We Do Anything About Health Disparities in America?

Keynote Address Can We Do Anything About Health Disparities in America? S. Leonard Syme, Ph.D., has been a Professor of Epidemiology at the University of California, Berkeley, since 1968. His major research interest has been psychosocial risk factors such as job stress, social support and poverty. In doing this research, he has studied San Francisco bus drivers; Japanese living in Japan, Hawaii and California; British civil servants; and people living in Alameda County, California. Dr. Syme has written two books and over 150 published papers, and has been a visiting professor at universities in England and Japan. He was elected to the Institute of Medicine of the National Academy of Sciences and has received several honors related to his teaching and research, among them, the Lilienfeld Award for Excellence in Teaching, the J.D. Bruce Award for Distinguished Contributions in Preventive Medicine from the American College of Preventive Medicine, and the University of California Distinguished Emeritus Professor Award

Factors influencing the relationship between the dose of amlodipine required for blood pressure control and change in blood pressure in hypertensive cats

BACKGROUND: Hypertension is a common problem in elderly cats. In most cats, systolic blood pressure (SBP) of <160 mmHg is achieved in response to amlodipine besylate at either 0.625 or 1.25 mg q24h. The individual cat factors determining dose requirement dose have not been explored. AIMS: To determine whether individual cat factors influence the dose of amlodipine required to achieve adequate blood pressure control and to determine whether factors other than the prescribed dose of drug alter the achieved plasma amlodipine concentrations. METHODS: Fifty‐nine hypertensive cats that required 0.625 mg (A) and 41 cats that required 1.25 mg (B) amlodipine to reach a target SBP of <160 mmHg were identified, and plasma amlodipine concentrations were determined. Comparisons were made between groups, and multivariable linear regression models were performed to investigate predictors of antihypertensive response. RESULTS: Cats that required a greater dose of amlodipine had significantly higher SBP at diagnosis of hypertension (A: (median [25th, 75th percentile]) 182 [175,192] mmHg; B: 207 [194,217] mmHg, P < .001), but comparable blood pressure was achieved after treatment. Plasma amlodipine concentrations were directly related to the dose of amlodipine administered. At diagnosis, cats in group B had significantly lower plasma potassium concentration (A: 4.1 [3.8,4.5]; B: 3.8 [3.6,4.2] mEq/L, P < .01). Weight did not differ between groups. The decrease in SBP was directly and independently associated with the SBP at diagnosis and the plasma amlodipine concentration. CONCLUSIONS AND CLINICAL IMPORTANCE: Cats with higher blood pressure at diagnosis might require a greater dose of amlodipine to control their blood pressure adequately. Differences in amlodipine pharmacokinetics between cats do not seem to play a role in the antihypertensive response

Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury

Chronic kidney disease (CKD) is a common medical condition of ageing cats. In most cases the underlying aetiology is unknown, but the most frequently reported pathological diagnosis is renal tubulointerstitial fibrosis. Renal fibrosis, characterised by extensive accumulation of extra-cellular matrix within the interstitium, is thought to be the final common pathway for all kidney diseases and is the pathological lesion best correlated with function in both humans and cats. As a convergent pathway, renal fibrosis provides an ideal target for the treatment of CKD and knowledge of the underlying fibrotic process is essential for the future development of novel therapies. There are many mediators and mechanisms of renal fibrosis reported in the literature, of which only a few have been investigated in the cat. This article reviews the process of renal fibrosis and discusses the most commonly cited mediators and mechanisms of progressive renal injury, with particular focus on the potential significance to feline CKD

Non-linear Pattern Matching with Backtracking for Non-free Data Types

Non-free data types are data types whose data have no canonical forms. For example, multisets are non-free data types because the multiset $\{a,b,b\}$ has two other equivalent but literally different forms $\{b,a,b\}$ and $\{b,b,a\}$. Pattern matching is known to provide a handy tool set to treat such data types. Although many studies on pattern matching and implementations for practical programming languages have been proposed so far, we observe that none of these studies satisfy all the criteria of practical pattern matching, which are as follows: i) efficiency of the backtracking algorithm for non-linear patterns, ii) extensibility of matching process, and iii) polymorphism in patterns. This paper aims to design a new pattern-matching-oriented programming language that satisfies all the above three criteria. The proposed language features clean Scheme-like syntax and efficient and extensible pattern matching semantics. This programming language is especially useful for the processing of complex non-free data types that not only include multisets and sets but also graphs and symbolic mathematical expressions. We discuss the importance of our criteria of practical pattern matching and how our language design naturally arises from the criteria. The proposed language has been already implemented and open-sourced as the Egison programming language

The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity

AbstractCryopreservation of stem cells after collection from peripheral blood or bone marrow for autologous transplantation necessitates protection with dimethyl sulfoxide (DMSO). Unfortunately, DMSO, when infused with the thawed cell suspension, may induce serious complications and side effects. To assess whether depletion of DMSO before autografting affects safety and efficacy, 56 consenting consecutive patients treated with high-dose chemotherapy and autologous blood stem cell transplantation were assigned to obtain either an untreated or DMSO-depleted autograft. On the day of transplantation, the cryopreserved cells were thawed and infused to the patient either immediately or after washing 3 times in normal saline supplemented with 6% anticoagulant citrate dextrose solution. Cell count with viability, clonogenic assay, and phenotyping were performed before and after thawing and after washing. Hematologic recovery, side effects, and complications were recorded. The in vitro and clinical data on 56 patients show that the depletion of DMSO in vitro before autografting does not induce a significant loss of cell number, viability, colony-forming unit-granulocyte-macrophage activity, or number of CD34+ cells. Furthermore, it leads to a safe and sustained engraftment. The complications and side effects, as recorded by continuous monitoring, were substantially less; however, the procedure takes 3 to 4 hours of laboratory work per patient